Mathematical Research Data Initiative
Main page
Recent changes
Random page
Help about MediaWiki
Create a new Item
Create a new Property
Create a new EntitySchema
Merge two items
In other projects
Discussion
View source
View history
Purge
English
Log in

Optimal adaptive two-stage designs for phase II cancer clinical trials

From MaRDI portal
Publication:2858002
Jump to:navigation, search

DOI10.1002/bimj.201200220zbMath1441.62339OpenAlexW1914095056WikidataQ51184477 ScholiaQ51184477MaRDI QIDQ2858002

Stefan Englert, Meinhard Kieser

Publication date: 19 November 2013

Published in: Biometrical Journal (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1002/bimj.201200220


zbMATH Keywords

branch-and-bound algorithmsample sizetwo-stage designadaptive designphase II clinical trial


Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)


Related Items (4)

An optimal design in a two-stage ethical allocation based on U-statistics ⋮ Optimal exact design of double acceptance sampling plans by attributes ⋮ Random norming AIDS analysis of non-linear regression models with sequential informative dose selection ⋮ Adaptive two-stage optimal designs for phase II clinical studies that allow early futility stopping



Cites Work

  • Adaptive Two-Stage Designs for Single-Arm Phase IIA Cancer Clinical Trials
  • Designed Extension of Studies Based on Conditional Power
  • Improving the Flexibility and Efficiency of Phase II Designs for Oncology Trials


This page was built for publication: Optimal adaptive two-stage designs for phase II cancer clinical trials

Retrieved from "https://portal.mardi4nfdi.de/w/index.php?title=Publication:2858002&oldid=15796960"
Tools
What links here
Related changes
Special pages
Printable version
Permanent link
Page information
MaRDI portal item
This page was last edited on 3 February 2024, at 19:24.
Privacy policy
About MaRDI portal
Disclaimers
Imprint
Powered by MediaWiki